27 February 2024Candesic is pleased to have assisted HBSUK with vendor commercial due diligence on its acquisition by insurance giant AXA Health on Friday. HBSUK supports public and…- 22 January 2024We are pleased to announce that Candesic provided vendor commercial due diligence to Centene Corporation in the context of their sale of Operose Health to HCRG Care…
- 13 December 2023Congratulations to the team at TPG on their majority investment in Outcomes First Group! Candesic provided commercial due diligence to TPG. Outcomes First Group is a leading…
- 29 November 2023Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners. Julius Clinical is a leading…
- 21 November 2023Congratulations to NorthEdge on their acquisition of Torbay Pharmaceuticals. Candesic provided commercial due diligence to NorthEdge. Torbay Pharmaceuticals is a fast growing specialist sterile injectable contract manufacturer. The…
- 8 November 2023Candesic is pleased to have provided commercial due diligence to Mayden, the leading electronic health record (EHR) for psychological therapies in the…
- 29 September 2023Gyrus Capital acquired LRE Medical, a provider of high-quality engineering solutions and manufacturing for medical equipment and life science diagnostics.…
- 11 September 2023Circle Health Group, the largest UK independent hospital operator, is to be sold for ca £1bn to PureHealth, the largest integrated…
- 10 August 2023Our team had the privilege of advising Gresham House Ventures on the investment into Mable Therapy. Mable Therapy is the…
- 11 July 2023We are pleased to announce our support to IK Partners in the recently completed acquisition of Medica Group for £271…
